Arkema SA (OTCMKTS:ARKAY - Get Free Report)'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $64.8401, but opened at $61.09. Arkema shares last traded at $61.00, with a volume of 5,151 shares.
Analyst Ratings Changes
ARKAY has been the subject of a number of recent analyst reports. Kepler Capital Markets downgraded shares of Arkema from a "strong-buy" rating to a "hold" rating in a research report on Friday, February 27th. Zacks Research lowered shares of Arkema from a "hold" rating to a "strong sell" rating in a research note on Tuesday, January 6th. The Goldman Sachs Group upgraded shares of Arkema from a "hold" rating to a "buy" rating in a research report on Tuesday, February 10th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Arkema from a "buy" rating to a "hold" rating in a report on Monday, November 24th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Reduce".
View Our Latest Analysis on Arkema
Arkema Price Performance
The company has a debt-to-equity ratio of 0.55, a current ratio of 3.07 and a quick ratio of 2.26. The firm has a market capitalization of $4.65 billion, a price-to-earnings ratio of 70.28, a PEG ratio of 1.55 and a beta of 0.87. The business's fifty day simple moving average is $65.74 and its 200 day simple moving average is $63.22.
Arkema Company Profile
(
Get Free Report)
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.